Medical News

RSS

Advocacy campaign to fight reimbursement cuts for POC urine drug screen devices

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, has announced the launch of an advocacy campaign to fight reimbursement cuts to point-of-care (POC) urine drug screen devices.

9 Sep 2009

Baucus sends $900 billion health care proposal to 'gang of six'

Sen. Max Baucus, D-Mont., chairman of the Senate Finance Committee, has sent his "gang of six" colleagues on the Senate Finance Committee a health overhaul proposal that would cost under $900 billion.

9 Sep 2009

Patent infringement lawsuit regarding DHA in functional foods ruled in favor of Martek

Martek Biosciences Corporation (Nasdaq: MATK) announced today that a panel of judges on the United States Court of Appeals for the Federal Circuit has ruled in Martek's favor in appeal proceedings related to a patent infringement lawsuit between Martek and Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH (collectively "Lonza").

9 Sep 2009

Global AIDS Coordinator Goosby believes Zimbabwe's ailing health system can be strengthened

Concluding his recent trip to Zimbabwe, the Global AIDS Coordinator for PEPFAR Eric Goosby said the country can rebuild and strengthen its health care delivery systems, the Zimbabwean reports. "I have seen fatigue in health care delivery in the country. A fatigue that that has come out of sustaining the response (to HIV and AIDS) with diminishing resources, but at the same time a feeling of hope and anticipation that they have hit bottom and are now on the return," Goosby said (9/4).

9 Sep 2009

AST scientific conference to emphasize on immunosuppression and tolerance

The American Society of Transplantation (AST) will present a scientific conference this winter that offers an in-depth, up-to-date look at immunosuppression and tolerance -- but with a brand new vibe. Called the Annual Scientific Exchange (ASE), slated for December 2-6, 2009, at the Marriott World Center in Orlando, Florida, it will differ from the typical conference in its format, which is specifically designed to be relaxed yet focused.

9 Sep 2009

Care-Tech Laboratories consents to end illegal manufacture and marketing of OTC drugs

The U.S. Food and Drug Administration today announced that St. Louis-based Care-Tech Laboratories Inc. and its principal officers, John C. Brereton and Sherry L. Brereton, have signed a consent decree, agreeing to stop the illegal manufacture, marketing, and distribution of over-the-counter (OTC) antimicrobial drugs used to treat and prevent infection.

9 Sep 2009

Helix Biopharma announces the closure of private placement of 6,625,000 units

Helix BioPharma Corp. (TSX, FSE: "HBP"; OTCQX: "HXBPF") today announced that it has closed its previously announced private placement of 6,625,000 units at $2.05 per unit.

9 Sep 2009

Rice researchers describe a new method to predict the efficacy of H1N1 vaccines

As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.

9 Sep 2009

Proposed Idaho nuclear plant to tackle critical shortage of lifesaving medical isotopes

Alternate Energy Holdings, Inc. (PINKSHEETS: AEHI) -- A critical worldwide shortage of nuclear isotopes has forced doctors to forgo lifesaving tests and increased testing cost -- underscoring the need for more nuclear reactors, according to AEHI, which is proposing to build a nuclear plant in Idaho.

9 Sep 2009

Preliminary Phase 3 clinical study results of T-Pred released

ISTA Pharmaceuticals, Inc., today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). The Company is developing T-Pred as a treatment for inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection exists, or there is a risk of bacterial infection.

9 Sep 2009

PBS special report on health care reform

With President Obama scheduled to give a major address on healthcare to a joint session of Congress this Wednesday, the hallmark PBS programs NOW ON PBS, TAVIS SMILEY and NIGHTLY BUSINESS REPORT are collaborating to provide a timely and much-needed in-depth look at health care reform in America and the latest government proposals to address the issue.

9 Sep 2009

Nexus launches Healthcare Practice

Nexus, a leading provider of advanced technology and network integration, announced the launch of a focused Healthcare Practice. Healthcare is one of the fastest growing industries today and currently generates a large percentage of Nexus' revenue.

9 Sep 2009

Nutrisystem D program helps overweight type 2 diabetic people lose weight

Results from a clinical study conducted at the Temple University School of Medicine and published today in the journal Postgraduate Medicine(1), show that a pre-packaged, portion controlled meal plan helped overweight individuals with type 2 diabetes lose significantly more weight and reduce their A1C test scores (a 90-day measure of blood sugar control) by almost a full point greater than those following a standard hospital-based diabetes support and education program, according to the findings.

9 Sep 2009

Majority of Americans are complacent about problems with their health plans: Study

Having problems with your health plan? If you speak up about it — or move on to another plan — you are a very unusual consumer, according to a new study.

9 Sep 2009

Hospitals in U.S. urban cities deliver low healthcare value

According to the most recent Hospital Value Index™ results, a study that analyzed data from more than 4,500 hospitals across the United States, hospitals in the largest U.S. cities generally offer a low value of patient care compared to elsewhere in the country.

9 Sep 2009

Meda launches EDLUAR in the U.S.

Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for the short-term treatment of insomnia characterized by difficulties with falling asleep. EDLUAR is the first available under-the-tongue formulation of zolpidem tartrate, which is the most prescribed treatment for insomnia. Zolpidem tartrate is also the active ingredient in Ambien(R) oral tablets.

9 Sep 2009

Obesity, alcohol and smoking linked to second breast cancer occurrence

It is well known that survivors of breast cancer have a much higher risk of developing a second breast cancer than women in the general population have of developing a first breast cancer. However, little is known about what lifestyle factors may make survivors more vulnerable to a second cancer.

9 Sep 2009

Increase in number of domestic H1N1 cases concerns China's Minister of Health

"China faces a grim situation in containing the H1N1 [swine] flu, as schools start up again and the number of domestic cases, as well as clusters of cases, rises, China's Minister of Health said on Tuesday," Reuters reports.

9 Sep 2009

Regular usage of CGM devices help manage diabetes

The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.

9 Sep 2009

Stocks of Medizone begin trading on the OTC Bulletin Board

Developer of ground-breaking ozone-based hospital sterilization technology -- AscepticSure(TM), Medizone announced today that its common stock has begun trading on the OTC Bulletin Board (OTC Bulletin Board: MZEI). The company's common stock was previously quoted on the Pink Sheets.

9 Sep 2009